Please log in to see the full text of this API!
Relugolix
-
Synonyms:
TAK-385; RVT-601
-
ATC:
H01CC54
-
Use:
Lorem
-
Chemical name:
Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam
-
Formula:
Lorem ipsum dolor sit amet,
-
MW:623.6 g/mol
-
CAS-RN:737789-87-6
-
InChI Key:AOMXMOCNKJTRQP-UHFFFAOYSA-N
-
InChI:InChI=1S/C29H27F2N7O5S/c1-36(2)14-19-24-26(39)38(22-12-13-23(42-3)34-33-22)29(41)37(15-18-20(30)6-5-7-21(18)31)27(24)44-25(19)16-8-10-17(11-9-16)32-28(40)35-43-4/h5-13H,14-15H2,1-4H3,(H2,32,35,40)
Substances Referenced in Synthesis Path
CAS-RN |
Formula |
Chemical Name |
CAS Index Name |
5332-96-7 |
C9H9NO3 |
4-nitrophenylacetone |
|
105-56-6 |
C5H7NO2 |
ethylcyanoacetate |
|
174072-89-0 |
C14H14N2O4S |
Ethyl 2-amino-4-methyl-5-(4-nitrophenyl)thiophene-3-carboxylate |
|
308831-93-8 |
C17H18N2O6S |
Ethyl 2-[(ethoxycarbonyl)amino]-4-methyl-5-(4-nitrophenyl)thiophene-3-carboxylate |
|
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Trade Names
Country |
Trade Name |
Vendor |
Annotation |
J |
Lorem |
Lorem
|
|
USA |
Lorem |
Lorem
|
|
EU |
Lorem |
Lorem
|
in comb. with estradiol and norethisterone acetate |
(wfm = withdrawn from market)
References
-
- Tukun, F. L. et al., Molecules, (2017) 22, 2188.
- Osuga, Y. et al., Fertility and Sterility, (2021), 115(2), 397-405.
- a) Miwa, K. et al., J. Med. Chem., (2011) 54, 4998-5012.
- Sasaki, S. et al., J. Med. Chem., (2003) 46, 113-124.
- US 9 999 999 (Takeda; 27.11.2007; appl. 29.7.2005; JP-prior. 28.1.2004).
- US 9 999 999 (Takeda; 15.11.2011; appl. 31.8.2007; JP-prior. 29.1.2003, 28.1.2004).
- b) WO 9999 999999 (Takeda; 3.4.2014; appl. 27.9.2013; JP-prior. 28.9.2012).
-
Alternative method:
- WO 9999 999999 (Suzhou Peng Xu Pharmatech; 11.2.2021; appl. 3.8.2020; CN-prior. 5.8.2019).
-
Treatment of prostate cancer:
- US 99 999 999 (Myovant Sci./Takeda; 29.9.2020; appl. 6.9.2019; EP-prior. 29.9.2017/US-prior. 30.9.2016).